14.06.2024 - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive officer, Derek Maetzold, has been named by Ernst & Young LLP (EY) . Seite 1
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares rose 8.8% during trading on Wednesday . The stock traded as high as $23.51 and last traded at $23.44. Approximately 139,605 shares were traded during trading, a decline of 42% from the average daily volume of 241,645 shares. The stock had previously closed at $21.55. Analyst […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 2,368 shares of Castle Biosciences stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $23.40, for a total transaction of $55,411.20. Following the transaction, the insider now directly owns 57,893 shares of the company’s […]
Olympiad Research LP Buys New Shares in Castle Biosciences, Inc (NASDAQ:CSTL) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.